For the nine months ended September 30, 2026, Utah Medical Products reported net sales of $25.87 million, a decrease from $29.48 million in the prior year period. Despite the decline in revenue, the company maintained profitability with a net income of $8.08 million and ended the period with a strong cash and investment balance of $85.20 million.
Utah Medical Products, Inc. (UTMD) announced that its Board of Directors has approved a 1.6% increase to its regular quarterly cash dividend. The new dividend of $0.315 per share is payable on January 5, 2027, to shareholders of record as of December 17, 2026.
Utah Medical Products Chairman, CEO Kevin L. Cornwell Buys $66.8K of Stock
Kevin L. Cornwell, Chairman, CEO, bought 1,000 shares of Utah Medical Products Inc at $66.75 a share, worth $66.8K in total on Oct 29, 2026. Shares held after the trade: 189,472 (+0.5%).
Utah Medical Products reported its 3Q 2026 financial results, showing a 12.1% decrease in consolidated revenues to $8.6 million compared to the prior year. Despite the revenue decline caused by the loss of two major customers, the company achieved a 6% increase in net income for the quarter, supported by the acquisition of Orion Medical Supplies Ltd in August 2026.